ArticleAmerican journal of clinical dermatology2025

Real-World Effectiveness, Safety, and Drug Survival of Risankizumab in Adult Patients with Plaque Psoriasis: A 3-Year Multicenter Retrospective Cohort Study.

Tiago Torres et al.PubMed ↗Publisher ↗

No numbers read from the abstract.